日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study

TAS-102联合苏鲁替尼治疗三线及后续转移性胰腺癌的疗效和安全性：一项前瞻性、单中心、生物标志物探索性II期研究

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-025-02437-0
Lu, Yunxin; Lin, Qingguang; Mo, Yongxin; Liu, Furong; Zhang, Mengwei; Huang, Runjie; Wang, Yun; Wang, Yinnan; Wang, Zhiqiang; Luo, Huiyan; Guo, Guifang; Chen, Jianwen; Liu, Yu; He, Mingming; Wang, Fenghua; Wang, Feng; Zhang, Dongsheng
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Comprehensive analysis of the functional and immunological significance of ETV4 in pan-cancer and its validation in digestive tumors.

对 ETV4 在泛癌中的功能和免疫学意义进行全面分析，并在消化系统肿瘤中验证其有效性

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1595850
Huang Lingli, Li Xujia, Huang Silan, Jiang Qi, Jiang Chang, He Wenzhuo, Cai Yuchen, Guo Guifang
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

EBV enhances immunotherapy sensitivity in intrahepatic cholangiocarcinoma through cGAS-STING pathway activation.

EBV 通过激活 cGAS-STING 通路增强肝内胆管癌的免疫治疗敏感性

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000674
Huang Lingli, Zhong Qian, Huang Silan, Yang Kejia, Cai Yuchen, Guo Guifang
肿瘤
胆管癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer

mFOLFIRINOX（或SOXIRI）联合吉西他滨加白蛋白结合型紫杉醇治疗不可切除胰腺癌的不同方案的疗效和安全性

期刊:ImmunoTargets and Therapy
影响因子:4.4
doi:10.2147/ITT.S530434
Huang, Silan; Huang, Lingli; Zhang, Dongsheng; Jiang, Qi; Wang, Fenghua; Guo, Guifang
胰腺癌
肿瘤
SOX
肿瘤免疫
发表日期：2025
文献求助 收藏

Integrating depression and acute coronary syndrome care in low resource hospitals in China: the I-CARE randomised clinical trial

在中国资源匮乏的医院中整合抑郁症和急性冠脉综合征的治疗：I-CARE随机临床试验

期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2024.101126
Wu, Yangfeng; Yu, Xin; Zhu, Yidan; Shi, Chuan; Li, Xian; Jiang, Ronghuan; Niu, Sheng; Gao, Pei; Li, Shenshen; Yan, Lijing; Maulik, Pallab K; Guo, Guifang; Patel, Anushka; Gao, Runlin; Blumenthal, James A
抑郁症
神经科学
发表日期：2024
文献求助 收藏

Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration

度伐利尤单抗联合化疗治疗晚期胆管癌的疗效及生物标志物探索

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03796-1
Lu, Yunxin; Jin, Yin; Liu, Furong; Wang, Zixian; Zhou, Wen; Zhang, Yang; Bai, Bing; Wang, Yun; Wang, Zhiqiang; Nie, Man; Luo, Huiyan; Wei, Xiaoli; Liang, Chuqiao; Guo, Guifang; Qiu, Miaozhen; Chen, Jianwen; Liu, Yu; Li, Shengping; Li, Yuhong; Wang, Fenghua; Wang, Feng; Chi, Peidong; Zhang, Dongsheng
肿瘤
胆管癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy

晚期胆道癌的解剖学分型可预测程序性细胞死亡蛋白1阻断疗法的疗效

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1375769
Huang, Lingli; Wang, Fang; Wang, Fenghua; Jiang, Qi; Huang, Jinsheng; Li, Xujia; Guo, Guifang
细胞生物学
肿瘤
胆管癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Highly Efficient Hemostatic Cross-Linked Polyacrylate Polymer Dressings for Immediate Hemostasis

高效止血交联聚丙烯酸酯聚合物敷料，可立即止血

期刊:Polymers
影响因子:
doi:10.3390/polym16060863
Tong Ye, Zhiyuan Yang, Ruolin Hao, Jinnan Guo, Guifang Dou, Zhiyun Meng, Shuchen Liu, Ruolan Gu, Zhuona Wu, Yunbo Sun, Peng Han, Yiguang Jin, Hui Gan
发表日期：2024
文献求助 收藏

Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer

SOXIRI方案与mFOLFIRINOX方案治疗晚期胰腺癌的疗效和安全性比较

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359231186029
Li, Xujia; Huang, Jinsheng; Wang, Fenghua; Jiang, Qi; Huang, Lingli; Li, Shengping; Guo, Guifang
胰腺癌
肿瘤
SOX
肿瘤免疫
发表日期：2023
文献求助 收藏

Magnesium isoglycyrrhizinate suppresses bladder cancer progression by modulating the miR-26b/Nox4 axis

异甘草酸镁通过调节 miR-26b/Nox4 轴抑制膀胱癌进展

期刊:Bioengineered
影响因子:4.2
doi:10.1080/21655979.2022.2031677
Zhihao Yuan, Guancheng Guo, Guifang Sun, Qi Li, Lihui Wang, Baoping Qiao
肿瘤
膀胱癌
发表日期：2022
文献求助 收藏